Cochleovestibular Screening in Neurosarcoidosis Patients

Neurosarcoidosis, a rare form of sarcoidosis affecting the nervous system, caused significant hearing and balance problems in a group of 21 patients studied at the University Hospital of Marrakech. Audiometric testing revealed hearing loss, tinnitus, and vertigo were common symptoms, often linked to granulomas impacting the vestibulocochlear nerve. Treatment with corticosteroids and immunosuppressants led to significant improvement for 57% of patients at follow-up.

How Neurosarcoidosis Damages Hearing and Balance

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas—small clusters of immune cells. When these granulomas infiltrate the nervous system, it becomes neurosarcoidosis. The condition can affect any part of the nervous system, but involvement of the cranial nerves is common. The vestibulocochlear nerve (the eighth cranial nerve), which carries signals for both hearing and balance from the inner ear to the brain, is a frequent target.

Researchers Achraf Hafdi, Mohammed Chehbouni, and Omar Oulghoul sought to document the specific auditory and vestibular consequences of this nerve involvement. Their work, published with the DOI 10.30574/ijsra.2026.19.2.1195, provides a clear picture of how this systemic disease manifests in the ear.

Study Methods: Measuring Sound and Movement

The team conducted a retrospective analysis of 21 patients diagnosed with neurosarcoidosis over a three-year period. Each patient received a comprehensive otolaryngological evaluation focused on cochleovestibular function.

The primary diagnostic tools were:

• Pure Tone Audiometry (PTA): This standard test measures hearing sensitivity across different frequencies, quantifying the degree and type of hearing loss.
• Video Nystagmography (VNG): This test records involuntary eye movements (nystagmus). It is a key method for assessing vestibular (balance) system function, as these eye movements are closely tied to inner ear signals.

These objective measures were correlated with clinical symptoms and radiological imaging, primarily MRI, which visualized the granulomas affecting neural structures.

Findings: Hearing Loss, Tinnitus, and Vertigo Are Common

The results showed a direct link between the disease’s physical presence and patient symptoms. Audiometric evaluation confirmed varying degrees of hearing loss in the cohort. Tinnitus (the perception of sound without an external source) and vertigo (a sensation of spinning or dizziness) were prominent complaints for many.

Imaging studies provided the anatomical explanation. They revealed sarcoid granulomas affecting multiple cranial nerves, with specific involvement of the vestibulocochlear nerve and surrounding areas in the brainstem. This physical disruption of the nerve pathways directly led to the measured hearing deficits and balance dysfunction.

Treatment Outcomes and Practical Implications

Management for neurosarcoidosis typically involves suppressing the abnormal immune response. Patients in this study were treated with corticosteroids and other immunosuppressive agents. The follow-up data showed this approach was effective for auditory and vestibular symptoms. A significant clinical improvement in hearing loss, tinnitus, and vertigo was observed, with 57% of patients reporting symptom improvement at their last assessment.

This finding has two major implications for clinical practice and patient awareness:

1. Neurosarcoidosis is a Diagnostic Consideration for Unexplained Symptoms

For individuals presenting with sudden or progressive hearing loss, persistent tinnitus, or vertigo—especially when accompanied by other neurological signs like facial weakness or vision changes—neurosarcoidosis should be part of the differential diagnosis. It is rare, but missing it delays effective treatment. This echoes the diagnostic challenge seen in other complex auditory conditions, such as the distinct pain pathways involved in pain hyperacusis.

2. Early, Targeted Treatment Can Reverse Symptoms

The study demonstrates that the cochleovestibular damage from neurosarcoidosis is not necessarily permanent. Early detection through a thorough work-up (including audiometry, vestibular testing, and neural imaging) allows for prompt immunosuppressive treatment, which can alleviate symptoms and potentially restore function. This principle of targeting the underlying neurological cause aligns with research approaches in other areas, such as strategies informed by neurodegenerative disease insights for tinnitus.

Connecting to Broader Hearing Health Research

While neurosarcoidosis is a specific systemic disease, its manifestation as hearing loss, tinnitus, and hyperacusis connects it to broader hearing health research. The improvement seen with medical treatment highlights that some forms of these symptoms are medically treatable when the root cause is identified. This is distinct from other forms of sound hypersensitivity, like misophonia, which are often managed through behavioral and neurological retraining strategies, such as those discussed in research on reversing loudness hypersensitivity.

The work by Hafdi, Chehbouni, and Oulghoul reinforces a central tenet in hearing health: a precise diagnosis is the foundation of effective management. For patients with puzzling auditory and balance symptoms, especially with broader neurological issues, investigating rare causes like neurosarcoidosis can be the key to meaningful recovery.